Global Telemedicine Market Research Report – Global Forecast Till 2023

Table of Contents

Table of Contents: 1 Report Prologue 2 Market Introduction 2.1 Introduction 2.2 Assumptions & Limitations 2.2.1 Assumptions 2.2.2 Limitations 2.3 Market Structure 3 Research Methodology 3.1 Research Process 3.2 Primary Research 3.3 Secondary Research 3.4 Market Size Estimation 4 Market Dynamics 4.1 Introduction 4.2 Drivers 4.2.1 Increasing adoption of EHR/EMR 4.2.2 Increasing prevalence of chronic diseases like diabetes, cancer, and others 4.2.3 The dearth of physicians in the presence of increasing healthcare services demands 4.3 Restraints 4.3.1 The high cost of implementing telemedicine systems like EMR & EHR and the need for training 4.3.2 Stringent government regulations 5 Market Factor Analysis 5.1 Porter’s Five Forces Analysis 5.1.1 Bargaining Power of Suppliers 5.1.2 Bargaining Power of Buyers 5.1.3 Threat of New Entrants 5.1.4 Threat of Substitutes 5.1.5 Intensity of Rivalry 5.2 Investment Opportunity Analysis 5.3 Value Chain Analysis 5.3.1 Inputs 5.3.2 Software Development Processes 5.3.3 Output 5.3.4 Marketing and Distribution 5.3.5 Post-selling Services 5.4 Regulatory Framework 5.4.1 Americas 5.4.2 Europe 5.4.2.1 Data Protection Directive 5.4.2.2 e-Commerce Directive 5.4.2.3 Medical Device Directives 5.4.2.4 Regulation on Distance Contracting 5.4.2.5 Directive on Electronic Signatures 5.4.2.6 Competition law 5.4.2.7 Directive on Professional Qualifications 5.4.2.8 Reimbursement 5.4.3 Russia 5.4.4 Asia Pacific 5.4.4.1 China 5.4.4.2 Japan 5.4.4.3 India 5.4.4.4 Australia 5.4.4.5 Singapore 5.4.4.5.1 Clinical Standards and Outcomes 5.4.4.5.2 Human Resources 5.4.4.5.3 Organisational 5.4.4.5.4 Technology and Equipment 5.4.5 The Middle East & Africa 5.4.5.1 Dubai 5.4.5.2 Abu Dhabi 6 Global Telemedicine Market, By Service Type 6.1 Introduction 6.2 Tele-Nursing 6.3 Tele-Pharmacy 6.4 Tele-Radiology 6.5 Tele-Dermatology 6.6 Tele-Oncology 7 Global Telemedicine Market, By Component 7.1 Introduction 7.2 Software 7.3 Hardware 8 Global Telemedicine Market, By Deployment 8.1 Introduction 8.2 Cloud Based 8.3 On Premises 9 Global Telemedicine Market, By Application 9.1 Introduction 9.2 Cardiology 9.3 Ophthalmology 9.4 Psychiatry 9.5 Radiology 9.6 Dermatology 10 Global Telemedicine Market, By End User 10.1 Introduction 10.2 Hospital 10.3 Clinic 10.4 Home care 11 Global Telemedicine Market: by Region 11.1 Americas 11.1.1 North America 11.1.1.1 US 11.1.1.1 Canada 11.1.2 South America 11.2 Europe 11.2.1 Western Europe 11.2.1.1 Germany 11.2.1.2 France 11.2.1.3 UK 11.2.1.4 Italy 11.2.1.5 Spain 11.2.1.6 Rest of Western Europe 11.2.2 Eastern Europe 11.3 Asia Pacific 11.3.1 China 11.3.2 India 11.3.3 Japan 11.3.4 Rest of Asia Pacific 11.4 The Middle East & Africa 11.4.1 United Arab Emirates 11.4.2 Saudi Arabia 11.4.3 Oman 11.4.4 Kuwait 11.4.5 Qatar 11.4.6 Rest of Middle East & Africa 12 Competitive Analysis 12.1 Company Market Share Analysis 12.1.1 Introduction 12.2 Competitive Landscape 12.2.1 Introduction 13 Company Profile 13.1 AMD Global Telemedicine, Inc. 13.1.1 Company Overview 13.1.2 Financials 13.1.3 Products 13.1.4 Strategy 13.1.5 Key Developments 13.2 BioTelemetry, Inc. 13.2.1 Company Overview 13.2.2 Financials 13.2.3 Products 13.2.4 Strategy 13.2.5 Key Developments 13.3 CareClix 13.3.1 Company Overview 13.3.2 Financials 13.3.3 Products 13.3.4 Strategy 13.3.5 Key Developments 13.4 Cerner Corporation 13.4.1 Company Overview 13.4.2 Financials 13.4.3 Products 13.4.4 Strategy 13.4.5 Key Developments 13.5 Cisco 13.5.1 Company Overview 13.5.2 Financials 13.5.3 Products 13.5.4 Strategy 13.5.5 Key Developments 13.6 GENERAL ELECTRIC 13.6.1 Company Overview 13.6.2 Financials 13.6.3 Products 13.6.4 Strategy 13.6.5 Key Developments 13.7 IBM Corporation 13.7.1 Company Overview 13.7.2 Financials 13.7.3 Products 13.7.4 Strategy 13.7.5 Key Developments 13.8 Intel Corporation 13.8.1 Company Overview 13.8.2 Financials 13.8.3 Products 13.8.4 Strategy 13.8.5 Key Developments 13.9 Iris Telehealth 13.9.1 Company Overview 13.9.2 Financials 13.9.3 Products 13.9.4 Strategy 13.9.5 Key Developments 13.1 Koninklijke Philips N.V. 13.10.1 Company Overview 13.10.2 Financials 13.10.3 Products 13.10.4 Strategy 13.10.5 Key Developments 13.11 Medtronic 13.11.1 Company Overview 13.11.2 Financials 13.11.3 Products 13.11.4 Strategy 13.11.5 Key Developments 13.12 SHL Telemedicine 13.12.1 Company Overview 13.12.2 Financials 13.12.3 Products 13.12.4 Strategy 13.12.5 Key Developments 13.13 TeleVital 13.13.1 Company Overview 13.13.2 Financials 13.13.3 Products 13.13.4 Strategy 13.13.5 Key Developments 14 MRFR Conclusion 14.1 Key Findings 14.1.1 From CEO’s View Point 14.2 Key Companies to Watch 15 Appendix 15.1 Discussion Blue Print 15.2 Recent Developments, 2013-2017